Anixa Biosciences Inc (ANIX)
3.49
+0.07
(+2.05%)
USD |
NASDAQ |
Sep 20, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Total Assets (Quarterly): 22.91M for July 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 22.91M |
| April 30, 2024 | 24.36M |
| January 31, 2024 | 25.37M |
| October 31, 2023 | 25.52M |
| July 31, 2023 | 26.58M |
| April 30, 2023 | 27.60M |
| January 31, 2023 | 28.31M |
| October 31, 2022 | 30.41M |
| July 31, 2022 | 32.56M |
| April 30, 2022 | 32.80M |
| January 31, 2022 | 35.24M |
| October 31, 2021 | 36.26M |
| July 31, 2021 | 37.06M |
| April 30, 2021 | 38.50M |
| January 31, 2021 | 14.60M |
| October 31, 2020 | 9.453M |
| July 31, 2020 | 9.362M |
| April 30, 2020 | 5.925M |
| January 31, 2020 | 6.164M |
| October 31, 2019 | 6.294M |
| July 31, 2019 | 6.843M |
| April 30, 2019 | 7.765M |
| January 31, 2019 | 6.470M |
| October 31, 2018 | 6.448M |
| July 31, 2018 | 7.294M |
| Date | Value |
|---|---|
| April 30, 2018 | 7.361M |
| January 31, 2018 | 7.491M |
| October 31, 2017 | 8.812M |
| July 31, 2017 | 8.415M |
| April 30, 2017 | 7.250M |
| January 31, 2017 | 4.218M |
| October 31, 2016 | 5.628M |
| July 31, 2016 | 6.321M |
| April 30, 2016 | 7.206M |
| January 31, 2016 | 8.647M |
| October 31, 2015 | 9.336M |
| July 31, 2015 | 10.28M |
| April 30, 2015 | 11.13M |
| January 31, 2015 | 13.27M |
| October 31, 2014 | 9.055M |
| July 31, 2014 | 13.40M |
| April 30, 2014 | 10.50M |
| January 31, 2014 | 10.33M |
| October 31, 2013 | 5.440M |
| July 31, 2013 | 5.308M |
| April 30, 2013 | 7.354M |
| January 31, 2013 | 7.522M |
| October 31, 2012 | 5.661M |
| July 31, 2012 | 5.887M |
| April 30, 2012 | 6.794M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.925M
Minimum
Apr 2020
38.50M
Maximum
Apr 2021
23.76M
Average
26.05M
Median
Total Assets (Quarterly) Benchmarks
| Annovis Bio Inc | 5.046M |
| Akero Therapeutics Inc | 865.04M |
| ACADIA Pharmaceuticals Inc | 914.10M |
| Amicus Therapeutics Inc | 749.48M |
| Intra-Cellular Therapies Inc | 1.321B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.217M |
| Shareholders Equity (Quarterly) | 21.77M |